Chrysalis 12 Inc. (V:RTO-P) — Market Cap & Net Worth
Market Cap & Net Worth: Chrysalis 12 Inc. (RTO-P)
Chrysalis 12 Inc. (V:RTO-P) has a market capitalization of $868.06K (CA$1.20 Million) as of April 21, 2026. Listed on the V stock exchange, this Canada-based company holds position #34440 globally and #1797 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chrysalis 12 Inc.'s stock price CA$0.10 by its total outstanding shares 12000000 (12.00 Million).
Chrysalis 12 Inc. Market Cap History: 2025 to 2026
Chrysalis 12 Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $1.04 Million to $868.06K (0.00% CAGR).
Chrysalis 12 Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Chrysalis 12 Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of RTO-P by Market Capitalization
Companies near Chrysalis 12 Inc. in the global market cap rankings as of April 21, 2026.
Key companies related to Chrysalis 12 Inc. by market ranking:
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #5662 globally with a market cap of $2.41 Billion USD ( ₩3.55 Trillion KRW).
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #11739 globally with a market cap of $655.09 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #12373 globally with a market cap of $587.05 Million USD.
- HCM II Acquisition Corp. Unit (NASDAQ:HONDU): Ranked #13003 globally with a market cap of $525.00 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5662 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $2.41 Billion | ₩32400.00 |
| #11739 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $655.09 Million | $10.01 |
| #12373 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #13003 | HCM II Acquisition Corp. Unit | NASDAQ:HONDU | $525.00 Million | $21.00 |
Chrysalis 12 Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, Chrysalis 12 Inc.'s market cap moved from $1.04 Million to $ 868.06K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$868.06K | -16.67% |
| 2025 | CA$1.04 Million | -- |
End of Day Market Cap According to Different Sources
On Apr 20th, 2026 the market cap of Chrysalis 12 Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $868.06K USD |
| MoneyControl | $868.06K USD |
| MarketWatch | $868.06K USD |
| marketcap.company | $868.06K USD |
| Reuters | $868.06K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Chrysalis 12 Inc.
Chrysalis 12 Inc. intends to identify and evaluate assets or businesses with a view to completing a qualifying transaction. The company was incorporated in 2024 and is headquartered in Toronto, Canada.